Using a tool for managing symptoms in palliative care
The MuSt-PC: A Multidimensional Strategy to Improve Quality of Life of Patients With Multiple Symptoms and Palliative Care Needs - Feasibility Study
This study is testing a new tool for managing symptoms in palliative care to see if healthcare providers find it helpful and easy to use with their patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20 (estimated) |
| Sex | All |
| Sponsor | University Medical Center Groningen Academic / other |
| Drugs / interventions | Radiation |
| Locations | 2 sites (Groningen and 1 other locations) |
| Trial ID | NCT06110624 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the intent of general healthcare providers (GHCPs) to use the MuSt-PC tool for symptom management in palliative care. GHCPs will be recruited from seven Centers of Expertise in Palliative Care and will receive training on how to use the tool. After applying MuSt-PC to five individual patients, they will provide feedback on their experiences through surveys. The goal is to assess the feasibility and acceptance of this tool in daily practice.
Who should consider this trial
Good fit: Ideal candidates for this study are healthcare providers in general practice, nursing homes, and hospitals who are involved in palliative care but are not specialists in the field.
Not a fit: Patients who are already receiving care from specialists in palliative care or those whose healthcare providers cannot independently make treatment decisions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance symptom management for patients in palliative care, leading to improved quality of life.
How similar studies have performed: While this approach is focused on the intent to use a specific tool, similar studies have shown promise in improving symptom management in palliative care settings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria:
Residents (in Dutch: Arts In Opleiding tot Specialist (AIOS) or Arts Niet In Opleiding tot Specialist (ANIOS)), medical specialists and nurse practitioners working in the following disciplines are invited to participate:
* General practice
* Nursing home
* Hospital:
* Clinical geriatrics
* Medical oncology
* Radiation oncology
* Pulmonology
* Cardiology
Exclusion Criteria:
HCPs who were formally trained in palliative care ("kaderopleiding palliatieve zorg", "Masteropleiding Palliative Medicine for Health Care Professionals at Cardiff University" or "post-HBO opleiding palliatieve zorg") and/or who have been or are currently a consultant of a palliative care consultation team are considered specialists in palliative care, are excluded from participation.
GHCPs (e.g. nurses) who cannot independently decide about CDSS recommendation adherence, including drug interventions, are excluded from participation.
Where this trial is running
Groningen and 1 other locations
- University Medical Center Groningen — Groningen, Netherlands (Recruiting)
- Lumc — Leiden, Netherlands (Recruiting)
Study contacts
- Principal investigator: An KL Reyners, MD, PhD — University Medical Center Groningen
- Study coordinator: AN KL Reyners, MD, PhD
- Email: a.k.l.reyners@umcg.nl
- Phone: +31503612821
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.